Overview

Emma is a corporate lawyer advising domestic and international clients on a range of business matters, including financings, mergers and acquisitions, go-public events, complex shareholder negotiations, corporate governance, commercial transactions, joint ventures and partnerships.

Emma's practice covers a broad range of sectors and industries, including life sciences, health care, SaaS, AI and quantum computing, clean tech, and natural resources. A large part of Emma’s practice focuses on supporting innovative growth companies and particularly in the life science industry. She helps create negotiated solutions among stakeholders, including founder exits, government contracts and complex shareholder agreements.

DCx Biotherapeutics in its licensing and acquisition of certain assets from Repare Therapeutics

Convergint in connection with its purchase of the security division of Delco Automation Inc.

Eupraxia in connection with its C$44.5-million non-brokered private placement of preferred shares

Alpha-9 Oncology in connection with its US$175-million Series C preferred share financing

Orpyx Medical in connection with its US$20-million financing by Perceptive Advisors

Disruption Ventures in connection with the C$1.5-million seed financing of Ginger Desk

Practice Areas

• Competition Law

Bar Information

Called to the bar: 2013 (ON)

Downloads

• vCard on firm website